MedPath

MRI Detection of Microbleeds in Glioma Patients

Completed
Conditions
Glioblastoma
Registration Number
NCT02899663
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Brief Summary

Systematic retrospective medical chart and medical imaging file review of all patients receiving brain MRI for the follow-up of glioblastoma.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
58
Inclusion Criteria
  • Adult patients
  • Diagnosed with brain glioblastoma
  • Receiving treatment with cranial radiotherapy and/or chemotherapy
  • Having at least one follow-up MRI conducted that used a susceptibility weighted imaging sequence
Exclusion Criteria
  • Underage
  • Absence of formal diagnosis of glioblastoma
  • No available medical imaging file with MRI susceptibility weighted imaging sequence

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of microbleeds diagnosed with MRI (susceptibility weighted imaging sequence)At the time of each MRI conducted within 5 years after diagnosis
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath